Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Nicole Gonzales

Concepts (309)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cerebral Hemorrhage
27
2024
125
4.240
 Why?
Stroke
39
2025
1270
3.290
 Why?
Neurology
6
2026
116
2.390
 Why?
Tissue Plasminogen Activator
23
2024
248
2.040
 Why?
Brain Ischemia
19
2025
359
1.700
 Why?
Fibrinolytic Agents
17
2024
297
1.520
 Why?
Thrombolytic Therapy
14
2024
164
1.400
 Why?
Sexism
1
2024
68
0.790
 Why?
Hematoma
6
2015
63
0.760
 Why?
Ischemic Attack, Transient
1
2023
71
0.740
 Why?
Endarterectomy, Carotid
4
2015
64
0.680
 Why?
Education, Medical
1
2024
275
0.640
 Why?
Platelet Aggregation Inhibitors
3
2022
499
0.640
 Why?
Women
1
2020
47
0.630
 Why?
Carotid Stenosis
4
2014
107
0.620
 Why?
Decompressive Craniectomy
1
2019
9
0.600
 Why?
Medicine
1
2020
125
0.570
 Why?
Matrix Metalloproteinases
1
2019
95
0.560
 Why?
Time-to-Treatment
2
2021
251
0.540
 Why?
Stents
5
2015
564
0.540
 Why?
Mobile Health Units
3
2024
20
0.520
 Why?
Percutaneous Coronary Intervention
1
2022
549
0.500
 Why?
Angioplasty
2
2014
50
0.490
 Why?
Attention
1
2020
461
0.480
 Why?
Brain Injuries
1
2020
507
0.430
 Why?
Cerebral Revascularization
1
2014
22
0.430
 Why?
Emergency Medical Services
5
2024
684
0.400
 Why?
Aged
39
2024
26153
0.400
 Why?
Humans
70
2026
145474
0.400
 Why?
Diffusion Tensor Imaging
2
2024
75
0.390
 Why?
Treatment Outcome
28
2023
11772
0.380
 Why?
Middle Aged
42
2025
36215
0.380
 Why?
Cerebral Ventricles
3
2024
56
0.380
 Why?
Hypertension
3
2016
1273
0.350
 Why?
Thiazolidinediones
2
2012
139
0.350
 Why?
Female
48
2026
78844
0.320
 Why?
Health Education
4
2023
346
0.310
 Why?
Male
49
2025
72842
0.310
 Why?
Disability Evaluation
3
2021
310
0.300
 Why?
Clinical Trials as Topic
6
2023
1061
0.280
 Why?
Prospective Studies
14
2024
8057
0.270
 Why?
Aged, 80 and over
19
2024
8333
0.260
 Why?
Schools
2
2007
448
0.250
 Why?
Time Factors
12
2025
7123
0.240
 Why?
Risk Factors
10
2025
10885
0.230
 Why?
Awareness
1
2007
110
0.230
 Why?
Demyelinating Autoimmune Diseases, CNS
1
2005
4
0.230
 Why?
Paraneoplastic Syndromes, Nervous System
1
2005
14
0.230
 Why?
Encephalomyelitis, Acute Disseminated
1
2005
11
0.230
 Why?
Lactation
1
2026
193
0.210
 Why?
Cerebral Blood Volume
1
2024
5
0.210
 Why?
Cerebral Intraventricular Hemorrhage
1
2024
6
0.210
 Why?
Anticoagulants
3
2019
748
0.210
 Why?
Healthcare Disparities
2
2024
735
0.200
 Why?
Workplace
1
2026
272
0.200
 Why?
American Heart Association
2
2023
358
0.200
 Why?
Skin Diseases, Vesiculobullous
1
2003
17
0.190
 Why?
Herpesvirus 2, Human
1
2003
27
0.190
 Why?
Encephalitis, Herpes Simplex
1
2003
21
0.190
 Why?
Pyramidal Tracts
1
2023
30
0.190
 Why?
Cytochrome P-450 CYP2C19
1
2022
26
0.190
 Why?
Antihypertensive Agents
3
2016
519
0.190
 Why?
Ambulances
2
2021
52
0.180
 Why?
Pilot Projects
5
2023
1891
0.180
 Why?
Academic Medical Centers
2
2024
554
0.180
 Why?
Hypoglycemic Agents
1
2012
1399
0.180
 Why?
Heterozygote
1
2022
313
0.180
 Why?
Health Status Disparities
1
2025
321
0.170
 Why?
PPAR gamma
3
2014
178
0.170
 Why?
Postoperative Complications
1
2014
2970
0.170
 Why?
Databases, Factual
3
2019
1490
0.170
 Why?
Adult
19
2025
40777
0.170
 Why?
Prognosis
6
2025
4316
0.170
 Why?
Health Promotion
2
2007
775
0.170
 Why?
Retrospective Studies
16
2025
17291
0.170
 Why?
Neuroprotective Agents
2
2015
147
0.170
 Why?
Faculty, Medical
1
2024
303
0.160
 Why?
Sex Factors
4
2025
2105
0.160
 Why?
Anxiety Disorders
1
2023
369
0.160
 Why?
United States
10
2024
16098
0.150
 Why?
Factor VIIa
2
2011
43
0.150
 Why?
Pipecolic Acids
2
2012
26
0.150
 Why?
Aspirin
1
2022
406
0.150
 Why?
Inpatients
1
2024
553
0.150
 Why?
Schools, Medical
1
2020
159
0.150
 Why?
Predictive Value of Tests
4
2019
2121
0.150
 Why?
Recovery of Function
3
2019
716
0.140
 Why?
Overweight
1
2023
614
0.140
 Why?
Edema
1
2019
125
0.140
 Why?
Isoenzymes
1
2019
294
0.140
 Why?
Health Services Needs and Demand
1
2020
280
0.140
 Why?
Glasgow Coma Scale
1
2019
218
0.130
 Why?
Adenocarcinoma
1
2005
925
0.130
 Why?
Dose-Response Relationship, Drug
4
2012
2028
0.130
 Why?
Disease Progression
3
2013
2864
0.130
 Why?
Genotype
1
2022
1852
0.130
 Why?
Mexican Americans
2
2009
119
0.130
 Why?
NF-E2-Related Factor 2
2
2015
101
0.130
 Why?
Propensity Score
1
2019
377
0.130
 Why?
Communication
1
2024
975
0.130
 Why?
Injury Severity Score
1
2019
599
0.120
 Why?
Hospital Mortality
2
2019
1038
0.120
 Why?
Platelet Transfusion
1
2017
77
0.120
 Why?
Severity of Illness Index
8
2024
2930
0.120
 Why?
Ultrasonography, Doppler, Transcranial
3
2013
48
0.120
 Why?
Decision Making
1
2023
977
0.120
 Why?
Anxiety
1
2023
1118
0.120
 Why?
Tomography, X-Ray Computed
4
2021
2769
0.110
 Why?
Texas
4
2013
272
0.110
 Why?
Fumarates
1
2015
10
0.110
 Why?
Microglia
2
2008
270
0.110
 Why?
Quality of Health Care
1
2020
692
0.110
 Why?
Anti-Inflammatory Agents
2
2011
477
0.110
 Why?
Pneumonia, Viral
1
2020
389
0.110
 Why?
Retinoid X Receptors
1
2014
38
0.110
 Why?
Recombinant Proteins
4
2011
1368
0.110
 Why?
Coronavirus Infections
1
2020
383
0.110
 Why?
Antithrombins
2
2013
71
0.110
 Why?
Blood Pressure
3
2011
1779
0.110
 Why?
Intraoperative Complications
1
2015
157
0.100
 Why?
Risk Assessment
2
2025
3747
0.100
 Why?
Cerebral Infarction
1
2014
47
0.100
 Why?
Neutrophil Infiltration
1
2014
104
0.100
 Why?
Single-Blind Method
1
2014
318
0.100
 Why?
Cohort Studies
7
2022
6013
0.100
 Why?
Odds Ratio
3
2021
1082
0.100
 Why?
Delivery of Health Care
1
2020
946
0.100
 Why?
Follow-Up Studies
4
2017
5423
0.100
 Why?
Perioperative Care
1
2015
231
0.100
 Why?
Quality Control
1
2013
161
0.090
 Why?
Registries
3
2025
2406
0.090
 Why?
Genetic Predisposition to Disease
1
2021
2378
0.090
 Why?
Medical Records
1
2013
192
0.090
 Why?
Sulfonamides
3
2012
583
0.090
 Why?
Biomarkers
2
2019
4295
0.090
 Why?
Lung Neoplasms
1
2005
2664
0.090
 Why?
Surveys and Questionnaires
2
2026
6066
0.090
 Why?
Carotid Artery, Internal
1
2011
45
0.090
 Why?
Telemedicine
2
2020
961
0.090
 Why?
Cyclooxygenase 2 Inhibitors
1
2011
24
0.090
 Why?
Cerebral Amyloid Angiopathy
1
2011
11
0.090
 Why?
Celecoxib
1
2011
42
0.080
 Why?
Collagen Type IV
1
2011
27
0.080
 Why?
Neurosurgical Procedures
1
2013
202
0.080
 Why?
Exercise
1
2023
2198
0.080
 Why?
Nervous System Diseases
1
2014
286
0.080
 Why?
Brain Edema
1
2011
62
0.080
 Why?
Carotid Arteries
1
2012
208
0.080
 Why?
History, 20th Century
1
2012
328
0.080
 Why?
NF-kappa B
1
2014
666
0.080
 Why?
Universities
1
2013
445
0.080
 Why?
Injections, Intra-Arterial
4
2013
26
0.080
 Why?
Nephrology
1
2011
60
0.080
 Why?
Platelet Glycoprotein GPIIb-IIIa Complex
1
2009
25
0.080
 Why?
Treatment Failure
2
2014
360
0.080
 Why?
Double-Blind Method
2
2012
2062
0.080
 Why?
Heparin
1
2011
247
0.070
 Why?
Health Care Surveys
1
2011
536
0.070
 Why?
Resuscitation Orders
1
2009
48
0.070
 Why?
Research Design
2
2013
1137
0.070
 Why?
Hand Transplantation
1
2008
9
0.070
 Why?
Intracranial Thrombosis
1
2008
19
0.070
 Why?
Venous Thrombosis
1
2011
196
0.070
 Why?
Caffeine
1
2009
74
0.070
 Why?
Neutrophils
1
2014
1124
0.070
 Why?
Hand Injuries
1
2008
33
0.070
 Why?
Adolescent
8
2025
22529
0.070
 Why?
Endovascular Procedures
1
2013
390
0.070
 Why?
Embolism
1
2008
48
0.070
 Why?
Hypothermia, Induced
1
2009
95
0.070
 Why?
Pyrazoles
1
2011
517
0.060
 Why?
Quality Improvement
1
2016
1295
0.060
 Why?
Practice Patterns, Physicians'
2
2017
1371
0.060
 Why?
Renal Dialysis
1
2011
466
0.060
 Why?
Nerve Fibers, Myelinated
1
2005
47
0.060
 Why?
Organ Transplantation
1
2008
251
0.060
 Why?
Methylprednisolone
1
2005
59
0.060
 Why?
Emergency Treatment
1
2006
123
0.050
 Why?
Teaching
1
2007
237
0.050
 Why?
Heart Diseases
1
2008
341
0.050
 Why?
Kidney Failure, Chronic
1
2011
599
0.050
 Why?
Paralysis
1
2005
69
0.050
 Why?
Brain Stem
1
2005
98
0.050
 Why?
Phagocytosis
3
2014
296
0.050
 Why?
Muscle Weakness
1
2005
92
0.050
 Why?
Injections, Intravenous
3
2011
197
0.050
 Why?
Fatal Outcome
1
2005
305
0.050
 Why?
Program Development
1
2007
368
0.050
 Why?
Quality-Adjusted Life Years
1
2024
123
0.050
 Why?
Administration, Intravenous
2
2017
172
0.050
 Why?
Young Adult
3
2025
14218
0.050
 Why?
Case-Control Studies
3
2021
3623
0.050
 Why?
Ethanol
1
2009
631
0.050
 Why?
Diffusion Magnetic Resonance Imaging
1
2005
155
0.050
 Why?
Emergency Service, Hospital
1
2016
2381
0.050
 Why?
Chi-Square Distribution
2
2017
527
0.050
 Why?
Peptides
1
2009
998
0.050
 Why?
Meningitis, Aseptic
1
2003
13
0.050
 Why?
Growth and Development
1
2023
9
0.050
 Why?
Principal Component Analysis
1
2023
193
0.050
 Why?
Spinal Cord
1
2005
382
0.050
 Why?
Hemorrhage
2
2023
822
0.050
 Why?
Headache
1
2003
151
0.040
 Why?
Catalase
2
2014
134
0.040
 Why?
Age Factors
2
2025
3342
0.040
 Why?
Students
1
2007
651
0.040
 Why?
Acute Disease
3
2011
1036
0.040
 Why?
Cost-Benefit Analysis
1
2024
639
0.040
 Why?
Respiratory Insufficiency
1
2005
326
0.040
 Why?
Certification
1
2023
119
0.040
 Why?
Partial Thromboplastin Time
2
2012
53
0.040
 Why?
Brain
1
2014
2947
0.040
 Why?
Reperfusion
2
2013
54
0.040
 Why?
DNA, Viral
1
2003
356
0.040
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
977
0.040
 Why?
Macrophages
1
2008
1507
0.040
 Why?
Practice Guidelines as Topic
3
2017
1581
0.040
 Why?
Hospital Bed Capacity
1
2020
27
0.040
 Why?
Guideline Adherence
2
2017
586
0.040
 Why?
Health Care Rationing
1
2020
56
0.040
 Why?
Ethics, Medical
1
2020
90
0.040
 Why?
Kaplan-Meier Estimate
2
2012
969
0.040
 Why?
Rats, Sprague-Dawley
2
2015
2524
0.040
 Why?
Health Resources
1
2020
130
0.040
 Why?
Magnetic Resonance Imaging
3
2023
3904
0.030
 Why?
Caregivers
1
2007
1073
0.030
 Why?
Logistic Models
2
2017
2134
0.030
 Why?
Incidence
1
2025
2923
0.030
 Why?
Combined Modality Therapy
2
2013
1266
0.030
 Why?
CD36 Antigens
2
2008
32
0.030
 Why?
Hospitals
1
2023
732
0.030
 Why?
Arginine
2
2012
264
0.030
 Why?
Autoantibodies
1
2005
1509
0.030
 Why?
Ventriculostomy
1
2017
24
0.030
 Why?
Betacoronavirus
1
2020
288
0.030
 Why?
Drug Therapy, Combination
2
2012
1044
0.030
 Why?
Statistics, Nonparametric
1
2017
428
0.030
 Why?
Rats
2
2015
5584
0.030
 Why?
Longitudinal Studies
1
2023
2953
0.030
 Why?
Dimethyl Fumarate
1
2015
12
0.030
 Why?
Disease Models, Animal
3
2014
4560
0.030
 Why?
Thrombocytopenia
1
2017
204
0.030
 Why?
Body Mass Index
1
2023
2445
0.030
 Why?
Neuroimmunomodulation
1
2014
67
0.030
 Why?
Perfusion Imaging
1
2014
66
0.030
 Why?
Intensive Care Units
1
2020
924
0.030
 Why?
Multivariate Analysis
1
2017
1547
0.020
 Why?
Biomedical Research
1
2020
717
0.020
 Why?
Animals
5
2015
38030
0.020
 Why?
Sex Distribution
1
2014
387
0.020
 Why?
Tomography Scanners, X-Ray Computed
1
2012
21
0.020
 Why?
Cerebral Veins
1
2012
16
0.020
 Why?
Erythrocytes
2
2008
748
0.020
 Why?
Health Services Accessibility
1
2020
1101
0.020
 Why?
Cerebral Arteries
1
2012
59
0.020
 Why?
Pandemics
1
2020
1707
0.020
 Why?
Plasminogen Activators
1
2011
7
0.020
 Why?
Heparin, Low-Molecular-Weight
1
2011
37
0.020
 Why?
Radiography
1
2013
852
0.020
 Why?
Quality of Life
1
2023
3204
0.020
 Why?
Mice, Inbred C57BL
2
2015
5983
0.020
 Why?
Analysis of Variance
1
2013
1300
0.020
 Why?
Magnetic Resonance Angiography
1
2012
251
0.020
 Why?
Obesity
1
2023
3116
0.020
 Why?
Length of Stay
1
2015
1349
0.020
 Why?
Buspirone
1
2009
5
0.020
 Why?
Meperidine
1
2009
6
0.020
 Why?
Shivering
1
2009
5
0.020
 Why?
Life Support Care
1
2009
42
0.020
 Why?
Adjuvants, Anesthesia
1
2009
13
0.020
 Why?
Mice
3
2015
18329
0.020
 Why?
Microspheres
1
2009
142
0.020
 Why?
Microcirculation
1
2009
142
0.020
 Why?
Brain Damage, Chronic
1
2008
18
0.020
 Why?
Anti-Anxiety Agents
1
2009
48
0.020
 Why?
Infusions, Intra-Arterial
1
2008
61
0.020
 Why?
Cerebral Angiography
1
2008
119
0.020
 Why?
Mice, Knockout
1
2015
3124
0.020
 Why?
Blood Flow Velocity
1
2009
421
0.020
 Why?
Behavior
1
2008
89
0.020
 Why?
Drug Combinations
1
2009
396
0.020
 Why?
Enzyme Activators
1
2007
9
0.020
 Why?
Infusions, Intravenous
1
2008
428
0.020
 Why?
Cultural Competency
1
2008
88
0.020
 Why?
Prostaglandin D2
1
2007
21
0.020
 Why?
Regression Analysis
1
2009
1001
0.020
 Why?
Urokinase-Type Plasminogen Activator
1
2006
25
0.020
 Why?
Nitric Oxide Synthase Type II
1
2007
162
0.020
 Why?
Deep Brain Stimulation
1
2009
219
0.010
 Why?
Graft Survival
1
2008
518
0.010
 Why?
Hydrogen Peroxide
1
2007
335
0.010
 Why?
Reproducibility of Results
1
2013
3413
0.010
 Why?
Recurrence
1
2008
1138
0.010
 Why?
Graft Rejection
1
2008
521
0.010
 Why?
Urban Population
1
2008
493
0.010
 Why?
Animals, Newborn
1
2007
891
0.010
 Why?
Self Efficacy
1
2008
410
0.010
 Why?
Recombinant Fusion Proteins
1
2006
666
0.010
 Why?
Myocardial Infarction
1
2011
1210
0.010
 Why?
Program Evaluation
1
2007
943
0.010
 Why?
Atrial Fibrillation
1
2008
558
0.010
 Why?
Curriculum
1
2007
1070
0.010
 Why?
Apoptosis
1
2008
2440
0.010
 Why?
Cells, Cultured
1
2007
4148
0.010
 Why?
Cytokines
1
2007
2067
0.010
 Why?
Parents
1
2007
1403
0.010
 Why?
Health Knowledge, Attitudes, Practice
1
2007
1419
0.010
 Why?
Neurons
1
2007
1649
0.010
 Why?
Child
1
2007
22707
0.000
 Why?
Gonzales's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (309) concept(s)
_
Co-Authors Expand Description
See all (14) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)